Clearstead Trust’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $170K | Buy |
947
+220
| +30% | +$39.5K | 0.03% | 189 |
|
2025
Q1 | $123K | Buy |
727
+22
| +3% | +$3.72K | 0.03% | 193 |
|
2024
Q4 | $106K | Hold |
705
| – | – | 0.02% | 201 |
|
2024
Q3 | $109K | Hold |
705
| – | – | 0.03% | 180 |
|
2024
Q2 | $96.5K | Sell |
705
-705
| -50% | -$96.5K | 0.02% | 187 |
|
2024
Q1 | $188K | Sell |
1,410
-535
| -28% | -$71.2K | 0.05% | 140 |
|
2023
Q4 | $268K | Buy |
1,945
+3
| +0.2% | +$414 | 0.07% | 140 |
|
2023
Q3 | $237K | Buy |
1,942
+3
| +0.2% | +$366 | 0.08% | 111 |
|
2023
Q2 | $273K | Buy |
1,939
+3
| +0.2% | +$422 | 0.09% | 107 |
|
2023
Q1 | $274K | Buy |
1,936
+2
| +0.1% | +$283 | 0.09% | 111 |
|
2022
Q4 | $303K | Buy |
1,934
+3
| +0.2% | +$470 | 0.1% | 100 |
|
2022
Q3 | $237K | Buy |
+1,931
| New | +$237K | 0.08% | 113 |
|